Analysis
France
Racine
Analysis
France
Exploration
Accueil
Racine
Racine

Serveur d'exploration Tocilizumab

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Jacques Morel And NotDrug-Related Side Effects and Adverse Reactions (epidemiology)

List of bibliographic references

Number of relevant bibliographic references: 25.
Ident.Authors (with country if any)Title
000009 Guillaume Decarriere [France] ; Thomas Barnetche [France] ; Bernard Combe [France] ; Cécile Gaujoux-Viala [France] ; Cédric Lukas [France] ; Jacques Morel [France] ; Claire Daien [France]The most appropriate conventional DMARD to combine with different advanced therapies in rheumatoid arthritis: a systematic literature review with meta-analysis.
000015 Jacques Morel [France] ; Marie Locci [France] ; Frédéric Banal [France] ; Bernard Combe [France] ; Grégoire Cormier [France] ; Maxime Dougados [France] ; René-Marc Flipo [France] ; Christian Marcelli [France] ; Thao Pham [France] ; Stéphanie Rist [France] ; Elizabeth Solau Gervais [France] ; Jean Sibilia [France] ; Cédric Lukas [France]Safety of surgery in patients with rheumatoid arthritis treated with tocilizumab: data from the French (REGistry -RoAcTEmra) Regate registry.
000050 Kedra Joanna [France] ; Philippe Dieudé [France] ; Hubert Marotte [États-Unis] ; Alexandre Lafourcade [France] ; Emilie Ducourau [France] ; Thierry Schaeverbeke [France] ; Aleth Perdriger [France] ; Martin Soubrier [France] ; Jacques Morel [France] ; Arnaud Constantin [Royaume-Uni] ; Emmanuelle Dernis [France] ; Valérie Royant [France] ; Jean-Hugues Salmon [France] ; Thao Pham [France] ; Jacques-Eric Gottenberg [France] ; Edouard Pertuiset [France] ; Maxime Dougados [France] ; Valérie Devauchelle-Pensec [France] ; Philippe Gaudin [France] ; Gregoire Cormier [France] ; Philippe Goupille [France] ; Xavier Mariette [France] ; Francis Berenbaum [France] ; Didier Alcaix [France] ; Sid Ahmed Rouidi [France] ; Jean-Marie Berthelot [France] ; Agnès Monnier [France] ; Christine Piroth [France] ; Frederic Liote [France] ; Vincent Goeb [France] ; Cécile Gaujoux-Viala [France] ; Isabelle Chary Valckenaere [France] ; David Hajage [France] ; Florence Tubach [France] ; Bruno Fautrel [France]Towards the lowest efficacious dose (toledo): results of a multicenter non-inferiority randomized open-label controlled trial assessing tocilizumab or abatacept injection spacing in rheumatoid arthritis patients in remission
000112 Jacques-Eric Gottenberg [France] ; Jacques Morel [France] ; Elodie Perrodeau [France] ; Thomas Bardin [France] ; Bernard Combe [France] ; Maxime Dougados [France] ; Rene-Marc Flipo [France] ; Alain Saraux [France] ; Thierry Schaeverbeke [France] ; Jean Sibilia [France] ; Martin Soubrier [France] ; Olivier Vittecoq [France] ; Gabriel Baron [France] ; Arnaud Constantin [France] ; Philippe Ravaud [France] ; Xavier Mariette [France]Comparative effectiveness of rituximab, abatacept, and tocilizumab in adults with rheumatoid arthritis and inadequate response to TNF inhibitors: prospective cohort study
000160 Jean-Hugues Salmon ; Jeanne-Marie Perotin ; Jacques Morel [France] ; Moustapha Dramé ; Alain Cantagrel [France] ; Liana Euller Ziegler ; Philippe Ravaud [France] ; Jean Sibilia ; Isabelle Pane [France] ; Xavier Mariette ; Jacques-Eric Gottenberg [France]Serious infusion-related reaction after rituximab, abatacept and tocilizumab in rheumatoid arthritis: prospective registry data.
000173 Cem Gabay [Suisse] ; Bruno Fautrel [France] ; Jürgen Rech [Allemagne] ; François Spertini [Suisse] ; Eugen Feist [Allemagne] ; Ina Kötter [Allemagne] ; Eric Hachulla [France] ; Jacques Morel [France] ; Thierry Schaeverbeke [France] ; Mohamed A. Hamidou [France] ; Thierry Martin [France] ; Bernhard Hellmich [Allemagne] ; Peter Lamprecht [Allemagne] ; Hendrik Schulze-Koops [Allemagne] ; Delphine Sophie Courvoisier [Suisse] ; Andrew Sleight [Suisse] ; Eduardo Jorge Schiffrin [Suisse]Open-label, multicentre, dose-escalating phase II clinical trial on the safety and efficacy of tadekinig alfa (IL-18BP) in adult-onset Still’s disease
000219 Jacques-Eric Gottenberg [France] ; Jacques Morel [France] ; Arnaud Constantin [Royaume-Uni] ; Thomas Bardin [France] ; Alain Cantagrel [France] ; Bernard Combe [France] ; Maxime Dougados [France] ; René-Marc Flipo [France] ; Alain Saraux [France] ; Thierry Schaeverbeke [France] ; Jean Sibilia [France] ; Martin Soubrier [France] ; Olivier Vittecoq [France] ; Gabriel Baron [France] ; Elodie Perrodeau [France] ; Philippe Ravaud [France] ; Xavier Mariette [France]Corticosteroid Sparing Effect of Non-TNF Targeted Biologics, Rituximab, Abatacept and Tocilizumab in Common Practice: Data from 3183 Patients Enrolled in the French Society of Rheumatology Registries
000220 Jacques Morel [France] ; Arnaud Constantin [France] ; Gabriel Baron [France] ; Emmanuelle Dernis [France] ; René-Marc Flipo [France] ; Stéphanie Rist [France] ; Bernard Combe [France] ; Jacques-Eric Gottenberg [France] ; Thierry Schaeverbeke [France] ; Martin Soubrier [France] ; Olivier Vittecoq [France] ; Maxime Dougados [France] ; Alain Saraux [France] ; Xavier Mariette [France] ; Philippe Ravaud [France] ; Jean Sibilia [France]Risk factors of serious infections in patients with rheumatoid arthritis treated with tocilizumab in the French registry REGATE
000239 Johanna Sigaux [France] ; Florian Bailly [France] ; David Hajage [France] ; Xavier Mariette [France] ; Jacques Morel [France] ; Frédérique Gandjbakhch [France] ; Violaine Foltz [France] ; Laure Gossec [France] ; Florence Tubach [France] ; Bruno Fautrel [France]Sustainability of TNF-blocker tapering in rheumatoid arthritis over 3 years: long-term follow-up of the STRASS (Spacing of TNF-blocker injections in Rheumatoid ArthritiS Study) randomised controlled trial
000242 Louise K. Mercer [Royaume-Uni] ; Anne C. Regierer [Allemagne] ; Xavier Mariette [France] ; William G. Dixon [Royaume-Uni] ; Eva Baecklund [Suède] ; Karin Hellgren [Suède] ; Lene Dreyer [Danemark] ; Merete Lund Hetland [Danemark] ; René Cordtz [Danemark] ; Kimme Hyrich [Royaume-Uni] ; Anja Strangfeld [Allemagne] ; Angela Zink [Allemagne] ; Helena Canhao [Portugal] ; M Victoria Hernandez [Espagne] ; Florence Tubach [France] ; Jacques-Eric Gottenberg [France] ; Jacques Morel [France] ; Jakub Zavada [République tchèque] ; Florenzo Iannone [Italie] ; Johan Askling [Suède] ; Joachim Listing [Allemagne]Spectrum of lymphomas across different drug treatment groups in rheumatoid arthritis: a European registries collaborative project
000245 Jacques Morel [France] ; Arnaud Constantin [France] ; Gabriel Baron [France] ; Emmanuelle Dernis ; René Marc Flipo ; Stéphanie Rist ; Bernard Combe [France] ; Jacques Eric Gottenberg [France] ; Thierry Schaeverbeke ; Martin Soubrier ; Olivier Vittecoq ; Maxime Dougados [France] ; Alain Saraux ; Xavier Mariette [France] ; Philippe Ravaud [France] ; Jean Sibilia [France]Risk factors of serious infections in patients with rheumatoid arthritis treated with tocilizumab in the French Registry REGATE.
000268 Yoann Ladner [France] ; Silvia Mas [France] ; Gaelle Coussot [France] ; Killian Bartley [France] ; Jérôme Montels [France] ; Jacques Morel [France] ; Catherine Perrin [France]Integrated microreactor for enzymatic reaction automation: An easy step toward the quality control of monoclonal antibodies.
000272 Johanna Sigaux [France] ; Moustafa Hamze [France] ; Claire Daien [France] ; Jacques Morel [France] ; Roman Krzysiek [France] ; Marc Pallardy [France] ; Bernard Maillere [France] ; Xavier Mariette [France] ; Corinne Miceli-Richard [France]Immunogenicity of tocilizumab in patients with rheumatoid arthritis.
000315 Louise K. Mercer [Royaume-Uni] ; Johan Askling [Suède] ; Pauline Raaschou [Suède] ; William G. Dixon [Royaume-Uni] ; Lene Dreyer [Danemark] ; Merete Lund Hetland [Danemark] ; Anja Strangfeld [Allemagne] ; Angela Zink [Allemagne] ; Xavier Mariette [France] ; Axel Finckh [Suisse] ; Helena Canhao [Portugal] ; Florenzo Iannone [Italie] ; Jakub Zavada [République tchèque] ; Jacques Morel [France] ; Jacques-Eric Gottenberg [France] ; Kimme L. Hyrich [Royaume-Uni] ; Joachim Listing [Allemagne]Risk of invasive melanoma in patients with rheumatoid arthritis treated with biologics: results from a collaborative project of 11 European biologic registers
000332 Coline Faivre [France] ; Axel Patrice Villani [France] ; François Aubin [France] ; Dan Lipsker [France] ; Martine Bottaro [France] ; Jean-David Cohen [France] ; François Durupt [France] ; Géraldine Jeudy [France] ; Emilie Sbidian [France] ; Eric Toussirot [France] ; Valérie Badot [Belgique] ; Sébastien Barbarot [France] ; Sébastien Debarbieux [France] ; Emmanuel Delaporte [France] ; Guetty Goegebeur [France] ; Jacques Morel [France] ; Aude Nassif [France] ; Gérard Duru [France] ; Denis Jullien [France]Hidradenitis suppurativa (HS): An unrecognized paradoxical effect of biologic agents (BA) used in chronic inflammatory diseases.
000368 Valérie Devauchelle-Pensec [France] ; Jacques-Eric Gottenberg [France] ; Sandrine Jousse-Joulin [France] ; Jean-Marie Berthelot [France] ; Aleth Perdriger [France] ; Eric Hachulla [France] ; Pierre Yves Hatron [France] ; Xavier Puechal [France] ; Véronique Le Guern [France] ; Jean Sibilia [France] ; Laurent Chiche [France] ; Vincent Goeb [France] ; Olivier Vittecoq [France] ; Claire Larroche [France] ; Anne Laure Fauchais [France] ; Gilles Hayem [France] ; Jacques Morel [France] ; Charles Zarnitsky [France] ; Jean Jacques Dubost [France] ; Philippe Dieudé [France] ; Jacques Olivier Pers [France] ; Divi Cornec [France] ; Raphaele Seror [France] ; Xavier Mariette [France] ; Emmanuel Nowak [France] ; Alain Saraux [France]Which and How Many Patients Should Be Included in Randomised Controlled Trials to Demonstrate the Efficacy of Biologics in Primary Sjögren’s Syndrome?
000387 Rachel Audo [France] ; Claire Daien [France] ; Laura Papon [France] ; Cédric Lukas [France] ; Olivier Vittecoq [France] ; Michael Hahne [France, Pays-Bas] ; Bernard Combe [France] ; Jacques Morel [France]Osteoprotegerin and tumor necrosis factor-related apoptosis-inducing ligand as prognostic factors in rheumatoid arthritis: results from the ESPOIR cohort
000395 Claire Immediato Daïen [France] ; Sarah Gailhac [France] ; Rachel Audo [France] ; Thibault Mura [France] ; Michael Hahne [France] ; Bernard Combe [France] ; Jacques Morel [France]High levels of natural killer cells are associated with response to tocilizumab in patients with severe rheumatoid arthritis.
000419 Alice Courties [France] ; Gilles Grateau ; Peggy Philippe ; René-Marc Flipo ; Leonardo Astudillo ; Bérengère Aubry-Rozier ; Isabelle Fabreguet ; Wafki Fahd ; Olivier Fain ; Pascal Guggenbuhl ; Eric Hachulla ; Thomas Papo ; Christophe Richez ; Jean Sibilia ; Jacques Morel ; Francis Berenbaum ; Jérémie SellamAA amyloidosis treated with tocilizumab: case series and updated literature review.
000445 Claire I. Daïen [France] ; Jacques Morel [France]Predictive Factors of Response to Biological Disease Modifying Antirheumatic Drugs: Towards Personalized Medicine
000601 Jacques Morel [France]Rhumatologie pédiatrique
000631 Claire Immediato Daïen [France] ; Yohan Duny [France] ; Thomas Barnetche [France] ; Jean-Pierre Daurès [France] ; Bernard Combe [France] ; Jacques Morel [France]Effect of TNF inhibitors on lipid profile in rheumatoid arthritis: a systematic review with meta-analysis
000684 Jacques Morel [France]Rhumatologie pédiatrique: stratégies thérapeutiques et tolérance des agents biologiques
000700 Thao Pham ; Pascal Claudepierre [France] ; Arnaud Constantin ; Michel De Bandt ; Bruno Fautrel [France] ; Laure Gossec [France] ; Jacques-Eric Gottenberg ; Philippe Goupille [France] ; Severine Guillaume [France] ; Eric Hachulla [France] ; Charles Masson ; Jacques Morel [France] ; Xavier Puechal ; Alain Saraux ; Thierry Schaeverbeke [France] ; Daniel Wendling ; Eric Bruckert [France] ; Stanislas Pol [France] ; Xavier Mariette [France] ; Jean SibiliaTocilizumab therapy and safety management
000703 Thao Pham [France] ; Pascal Claudepierre ; Arnaud Constantin ; Michel De Bandt ; Bruno Fautrel ; Laure Gossec ; Jacques-Eric Gottenberg ; Philippe Goupille ; Séverine Guillaume ; Eric Hachulla ; Charles Masson ; Jacques Morel ; Xavier Puéchal ; Alain Saraux ; Thierry Schaeverbeke ; Daniel Wendling ; Eric Bruckert ; Stanislas Pol ; Xavier Mariette ; Jean SibiliaTocilizumab: therapy and safety management.
Wicri

This area was generated with Dilib version V0.6.34.
Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021